Piramal Pharma Limited



Disclosure under Regulation 30 of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015 FDA Inspection |SUBJECT: General Updates



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *